CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...
Phase 3
Westwood, Kansas, United States and 153 other locations
in patients with platinum-resistant high-grade epithelial ovarian cancer, primary peritoneal, or fallopian tube cancer, wh...
Phase 3
Kansas City, Missouri, United States and 207 other locations
maintenance treatment in participants with advanced (stage IIIB-IV) ovarian cancer, fallopian tube cancer, or primary peri...
Phase 2
Kansas City, Missouri, United States and 27 other locations
ecteribulin (MORAb-202) and compare it to Investigator's choice (IC) chemotherapy in female participants with platinum-resistant HGS ovarian....
Phase 2
Kansas City, Kansas, United States and 82 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
Westwood, Kansas, United States and 21 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Westwood, Kansas, United States and 237 other locations
ultralow dose gemcitabine in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma ba...
Phase 1, Phase 2
Kansas City, Missouri, United States and 67 other locations
The primary objective of this study is to evaluate progression-free survival (PFS) by blinded independent central review (BICR) in patients treated w...
Phase 3
Overland Park, Kansas, United States and 116 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Kansas City, Kansas, United States and 92 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
Kansas City, Missouri, United States and 123 other locations
Clinical trials
Research sites
Resources
Legal